• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有抗SARS-CoV-2活性的天然产物及其衍生物的药理相关性与化学合成进展

An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity.

作者信息

Ahmad Irshad

机构信息

Department of Mathematics and Natural Sciences School of Arts and Sciences American University of Ras Al Khaimah Ras Al Khaimah Road, P. O. Box 10021 Ras Al Khaimah, UAE.

出版信息

ChemistrySelect. 2021 Nov 15;6(42):11502-11527. doi: 10.1002/slct.202103301. Epub 2021 Nov 8.

DOI:10.1002/slct.202103301
PMID:34909460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8661826/
Abstract

Natural products recognized traditionally as a vital source of active constituents in pharmacotherapy. The COVID-19 infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible, pathogenic, and considered an ongoing global health emergency. The emergence of COVID-19 globally and the lack of adequate treatment brought attention towards herbal medicines, and scientists across the globe instigated the search for novel drugs from medicinal plants and natural products to tackle this deadly virus. The natural products rich in scaffold diversity and structural complexity are an excellent source for antiviral drug discovery. Recently the investigation of several natural products and their synthetic derivatives resulted in the identification of promising anti SARS-CoV-2 agents. This review article will highlight the pharmacological relevance and chemical synthesis of the recently discovered natural product and their synthetic analogs as SARS-CoV-2 inhibitors. The summarized information will pave the path for the natural product-based drug discovery of safe and potent antiviral agents, particularly against SARS-CoV-2.

摘要

天然产物传统上被认为是药物治疗中活性成分的重要来源。由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病感染具有高度传染性和致病性,被视为持续的全球卫生紧急事件。2019冠状病毒病在全球的出现以及缺乏足够的治疗方法,使人们将注意力转向草药,全球科学家开始从药用植物和天然产物中寻找新型药物来对抗这种致命病毒。富含支架多样性和结构复杂性的天然产物是抗病毒药物发现的极佳来源。最近,对几种天然产物及其合成衍生物的研究导致了有前景的抗SARS-CoV-2药物的鉴定。这篇综述文章将重点介绍最近发现的天然产物及其合成类似物作为SARS-CoV-2抑制剂的药理学相关性和化学合成。总结的信息将为基于天然产物的安全有效抗病毒药物的发现铺平道路,特别是针对SARS-CoV-2的药物。

相似文献

1
An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS-CoV-2 Activity.具有抗SARS-CoV-2活性的天然产物及其衍生物的药理相关性与化学合成进展
ChemistrySelect. 2021 Nov 15;6(42):11502-11527. doi: 10.1002/slct.202103301. Epub 2021 Nov 8.
2
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
3
Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.利用天然化合物靶向 SARS-CoV-2 感染的药物发现的当前方法。
Virus Res. 2020 Dec;290:198169. doi: 10.1016/j.virusres.2020.198169. Epub 2020 Sep 24.
4
Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.利用化学信息学和机器学习探索严重急性呼吸综合征冠状病毒2(SARS-CoV-2)潜在小分子抑制剂的可用化学空间。
Comput Struct Biotechnol J. 2021;19:424-438. doi: 10.1016/j.csbj.2020.12.028. Epub 2020 Dec 29.
5
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).药用植物和次生代谢物抗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的作用机制。
Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130.
6
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects.海洋天然产物在抗SARS-CoV-2抗病毒药物研发中的作用:潜力与前景
Mar Life Sci Technol. 2024 Feb 21;6(2):280-297. doi: 10.1007/s42995-023-00215-9. eCollection 2024 May.
7
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
8
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective.天然产物作为 SARS-CoV-2 的潜在治疗剂:药物化学视角。
Curr Top Med Chem. 2023;23(17):1664-1698. doi: 10.2174/1568026623666230327125918.
9
Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection.扭转局势:天然产物及受天然产物启发的化学品有望对抗新冠病毒感染
Front Pharmacol. 2020 Jul 2;11:1013. doi: 10.3389/fphar.2020.01013. eCollection 2020.
10
Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.天然产物:用于治疗COVID-19的抗病毒药物候选先导物的丰富来源。
Curr Pharm Des. 2021;27(33):3526-3550. doi: 10.2174/1381612826666201118111151.

引用本文的文献

1
Functional Characterization of -Glucuronidase Genes Involved in Baicalein Biosynthesis from Based on Transcriptome Analysis.基于转录组分析对来源于[具体来源未给出]的参与黄芩苷生物合成的β-葡萄糖醛酸酶基因的功能表征
Int J Mol Sci. 2025 Feb 20;26(5):1793. doi: 10.3390/ijms26051793.
2
Modulating Effects of the Hydroethanolic Leaf Extract of R. Br. Soják (Polygonaceae) against Acute Inflammation.水醇提瑞香狼毒叶提取物对急性炎症的调节作用。
ScientificWorldJournal. 2023 Jul 10;2023:5567410. doi: 10.1155/2023/5567410. eCollection 2023.
3
Flavonoids from the roots and rhizomes of Sophoratonkinensis and their in vitro anti-SARS-CoV-2 activity.从苦参根和根茎中分离得到的类黄酮及其体外抗 SARS-CoV-2 活性。
Chin J Nat Med. 2023 Jan;21(1):65-80. doi: 10.1016/S1875-5364(23)60386-3.
4
Effects of Resveratrol, Curcumin and Quercetin Supplementation on Bone Metabolism-A Systematic Review.白藜芦醇、姜黄素和槲皮素补充剂对骨代谢的影响——系统评价。
Nutrients. 2022 Aug 26;14(17):3519. doi: 10.3390/nu14173519.
5
Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.有潜力的抗 SARS-CoV-2 天然产物:结构、功能和临床试验。
Phytother Res. 2022 Oct;36(10):3833-3858. doi: 10.1002/ptr.7580. Epub 2022 Aug 5.
6
Heterologous Biosynthesis of Health-Promoting Baicalein in .在...中异源生物合成具有保健作用的白杨素。
Molecules. 2022 May 11;27(10):3086. doi: 10.3390/molecules27103086.
7
Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature.白藜芦醇补充对微生物组调节的益处和影响:文献系统评价。
Int J Mol Sci. 2022 Apr 5;23(7):4027. doi: 10.3390/ijms23074027.

本文引用的文献

1
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.抗2019冠状病毒病的抗病毒药物:基于结构设计的严重急性呼吸综合征冠状病毒2主蛋白酶特异性拟肽抑制剂
RSC Adv. 2020 Nov 4;10(66):40244-40263. doi: 10.1039/d0ra08304f. eCollection 2020 Nov 2.
2
The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.甘草酸和甘草提取物在对抗 COVID-19 及其相关病症方面的潜力。
Phytomed Plus. 2021 Aug;1(3):100043. doi: 10.1016/j.phyplu.2021.100043. Epub 2021 Feb 17.
3
Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences.低剂量吐根碱作为潜在的抗SARS-CoV-2病毒疗法:临床前体外抑制和体内药代动力学证据
Mol Biomed. 2020;1(1):14. doi: 10.1186/s43556-020-00018-9. Epub 2020 Nov 30.
4
A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)现有或正在研发的疫苗及技术概述。
Pathogens. 2021 Jun 22;10(7):788. doi: 10.3390/pathogens10070788.
5
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
6
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.长新冠或新冠后综合征:推测的病理生理学、危险因素和治疗方法。
Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22.
7
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease.甘草酸通过抑制病毒主蛋白酶有效抑制 SARS-CoV-2 复制。
Viruses. 2021 Apr 2;13(4):609. doi: 10.3390/v13040609.
8
Long COVID: An overview.长新冠:概述。
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875. doi: 10.1016/j.dsx.2021.04.007. Epub 2021 Apr 20.
9
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.
10
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals.抗击新冠病毒的新挑战:病毒变种、潜在疫苗及抗病毒药物的研发
Biosci Trends. 2021 May 11;15(2):126-128. doi: 10.5582/bst.2021.01092. Epub 2021 Mar 19.